Thursday, December 25, 2025 | 07:42 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Marksans Pharma Ltd / Announcements / BSE

Marksans Pharma Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

01:06 PM, 20th Nov 2025

Marksans Pharma Limiteds wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its product Cetirizine Dihydrochloride 1 mg/ml oral solution from UK MHRA.

More Marksans Pharma Ltd Announcements

    View more
    Business Standard
    HOT STOCKS
    TOP SECTIONS
    KEY EVENTS
    Copyrights © 2025 Business Standard Private Ltd. All rights reserved
    LinkedIN Icon